MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice

Vaccine

Volumn 14, Issue 6, 1996, Pages 478-484

  Higgins, Deborah A ^a   Carlson, Julia R ^a   Van Nest, Gary ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adjuvant; Age; Influenza

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;

AGED; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; AGING; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; DRUG SYNERGISM; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; POLYSORBATES; SPLEEN; SQUALENE;

EID: 0030012890     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00240-2     Document Type: Article

References (34)

1. Ligthart, G.J., Corberand, J.X., Fournier, C. et al. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mechanisms Ageing Dev. 1984, 28, 47-55
2. Ligthart, G.J., Coeberand, J.Z., Geertzen, H.G.M., Meinders, A.E., Knook, D.L. and Hijmans, W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the Senieur protocol. Mechanisms Ageing Dev. 1990, 55, 89-105
3. Hobson, D., Baker, F.A. and Curry, R.L. Effects of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet 1973, i, 155-156
4. Palache, A.M., Beyer, W.E.P., Sprenger, M.J.W. et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 1993, 11, 3-9
5. Phair, J., Kauffman, C.A., Bjornson, A., Adams, L. and Linnemann, C. Jr. Failure to respond to influenza vaccine in the aged: Correlation with B-cell number and function. J. Lab. Clin. Med. 1978, 92, 822-828
6. Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 1993, 167, 584-592
7. Remarque, E.J., van Seek, W.C.A., Ligthart, G.J. et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993, 11, 649-654
8. Sundquist, B., Lovgren, K. and Morein, B. Influenza virus ISCOMs: antibody response in animals. Vaccine 1988, 6, 49-53
9. Fattal-German, M., German, A. and Bizzini, B. Potentiating the effectiveness of influenza vaccination by a combined immunostimulation with P40 immunomodulator, an experimental study in mice. Biomed. Pharmacother. 1988, 42, 73-78
10. Mbawuike, I.N., Wyde, P.R. and Anderson, R.M. Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes. Vaccine 1990, 8, 347-352
11. Byars, N.E., Allison, A.C., Harmon, M.W. and Kendal, A.P. Enhancement of antibody response to influenza B virus haemagglutinin by use of a new adjuvant formulation. Vaccine 1990, 8, 49-56
12. Keitel, W., Couch, R., Bond, N., Adair, S., Van Nest, G. and Dekker, C. Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant. Vaccine 1993, 11, 909-914
13. Kaji, M., Kaji, Y., Kaji, M. et al. Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382). Vaccine 1992, 10, 663-667
14. Gravenstein, S., Drinka, P., Duthie, E.H. et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J. Am. Geriat. Soc. 1994, 42, 245-251
15. Van Nest, G.A., Steimer, K.S., Haigwood, N.L., Burke, R.L. and Ott, G. Advanced adjuvant formulations for use with recombinant subunit vaccines. In: Vaccines 92. Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, 1992, pp. 57-62
16. Ott, G., Barchfeld, G.L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P. and Van Nest, G. MF59. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 277-296
17. Burke, R.L. Current status of HSV vaccine development. In: The Human Herpesviruses (Eds Roizman B., Whitley R.J. and Lopez, C.). Raven Press Ltd, New York, 1993, pp. 367-379
18. Kahn, J.O., Sinangil, F., Baenziger, J. et al. Clinical and immunologic responses to Human Immunodeficiency Virus (HIV) Type 1 SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers. J. Infect. Dis. 1994, 170, 1288-1291
19. Martin, T., De Donato, S., Minutello, A. et al. Safety and immunogenicity of Biocine adjuvanted influenza vaccine in elderly subjects. 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995 (abstract)
20. Valensi, J.P.M., Carlson, J.R. and Van Nest, G.A. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 1994, 153, 4029-4039
21. Recommendations of the Immunization Practices Advisory Committee (ACIP). Prevention and control of influenza: Part I, Vaccines. Morbid. Mortal. Wkly Rep. 1994, 43, RR-9,1-13
22. Strassburg, M.A., Greenland, S., Sorvillo, F.J., Lieb, L.E. and Habel, L.A. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4, 38-44
23. Bender, B.S. and Small, P.A. Jr. Heterotypic immune mice lose protection against influenza virus infection with senescence. J. Infect. Dis. 1993, 168, 873-880
24. Waldman, R.H., Bergmann, K.C., Stone, J. et al. Age-dependent antibody response in mice and humans following oral influenza immunization. J. Clin. Immunol. 1987, 7, 327-332
25. Beyer, W.E.P., Palache, A.M., Baljet, M. and Masurel, N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989, 7, 385-394
26. Potter, C.W. and Oxford, J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 1979, 35, 69-75
27. Ott, G., Barchfeld, G.L. and Van Nest, G. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 1995, 13, 1557-1562
28. Kishimoto, S., Tomino, S., Inomata, K. et al. Age-related changes in the subsets and functions of human T lymphocytes. J. Immunol. 1978, 121, 1773-1780
29. Beckman, I., Dimopoulos, K., Xaioning, X., Bradley, J., Henschke, P. and Ahern, M. T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions. Mechanisms Ageing Dev. 1990, 51, 265-276
30. Charpentier, B., Fournier, C., Fries, D., Mathieu, D., Noury, J. and Bach, J.F. Immunological studies in human ageing I. In vitro functions of T cells and polymorphs. J. Clin. Lab. Immunol. 1981, 5, 87-93
31. Antel, J.P., Oger, J.J.-F., Dropcho, E., Richman, D.P., Kuo, H.H. and Arnason, B.G.W. Reduced T-lymphocyte cell reactivity as a function of human ageing. Cell. Immunol. 1980, 54, 184-192
32. Wedelin, C., Bjorkholm, M., Holm, G., Ogenstad, S. and Mellstedt, H. Blood T-lymphocyte functions in healthy adults in relation to age. Scand. J. Haematol. 1982, 28, 45-53
33. McElhaney, J.E., Beattie, B.L., Devine, R., Grynoch, R., Toth, E.L. and Bleackley, R.C. Age-related decline in interleukin 2 production in response to influenza vaccine. J. Am. Geriat. Soc. 1990, 38, 652-658
34. Voth, D.W., Feldman, H.A. and Steinschneider, A. Comparative responses of elderly persons to aqueous and depot influenza vaccines. Arch. Environ. Hlth 1966, 13, 576-585